Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ALPHACATENIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Gene Symbol | ALPHACATENIN |
| Protein Family | Alpha-catenin family, Vinculin family |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 100 kDa |
| UniProt ID | P35221 |
| GeneCards | ALPHACATENIN |
| Human Protein Atlas | ALPHACATENIN |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ACTN["ALPHA-CATENIN"]
BCTN["beta-Catenin"]
ECAD["E-Cadherin"]
ACTIN["Actin Cytoskeleton"]
AJ["Adherens Junctions"]
BBB["Blood-Brain Barrier"]
SYN["Synaptic Stability"]
WNT["Wnt Signaling"]
GSK3B["GSK-3beta"]
NEURO["Neurodegeneration"]
AD["Alzheimer's Disease"]
INFLAM["Neuroinflammation"]
APOP["Neuronal Apoptosis"]
PERM["BBB Permeability"]
LOSS["Synaptic Loss"]
PROT["Neuroprotection"]
ACTN -->|"binds"| BCTN
ACTN -->|"links to"| ACTIN
BCTN -->|"forms complex"| ECAD
ACTN -->|"stabilizes"| AJ
AJ -->|"maintains"| BBB
AJ -->|"supports"| SYN
ACTN -->|"regulates"| WNT
WNT -->|"inhibits"| GSK3B
GSK3B -->|"promotes"| APOP
ACTN -->|"dysfunction leads to"| NEURO
NEURO -->|"manifests as"| AD
BBB -->|"breakdown causes"| INFLAM
SYN -->|"destabilization causes"| LOSS
INFLAM -->|"accelerates"| NEURO
LOSS -->|"contributes to"| NEURO
ACTN -->|"when functional"| PROT
classDef central fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#fff
classDef protective fill:#1a3a2a,stroke:#81c784,stroke-width:2px,color:#fff
classDef pathological fill:#3a1a1a,stroke:#ef5350,stroke-width:2px,color:#fff
classDef regulatory fill:#2a1a3a,stroke:#ce93d8,stroke-width:2px,color:#fff
classDef disease fill:#3a2a1a,stroke:#ffa726,stroke-width:2px,color:#fff
class ACTN central
class BBB,SYN,AJ,PROT protective
class NEURO,INFLAM,APOP,PERM,LOSS pathological
class WNT,GSK3B,BCTN,ECAD,ACTIN regulatory
class AD disease| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ALPHACATENIN in their description or question text
No additional research found